Trademark: 79045881
Word
QFT
Status
Dead
Status Code
404
Status Date
Friday, September 15, 2017
Serial Number
79045881
Registration Number
3654831
Registration Date
Tuesday, July 14, 2009
Mark Type
3000
Filing Date
Friday, September 14, 2007
Published for Opposition
Tuesday, April 28, 2009
Cancellation Date
Friday, September 15, 2017

Trademark Owner History
Cellestis Limited - Original Registrant

Classifications
1 Chemical and biological reagents for use in vitro diagnostic test kits for laboratory and research use; chemical and biological peptides for laboratory or research use; chemical and biological antigens for laboratory and research use; chemical and biological mitogens for laboratory and research use; in vitro diagnostic test kits to aid the detection of infection and cell mediated immune responses for scientific and research use; assays for laboratory and research use; biological tissue, namely, blood stem cells, plasma, umbilical cords and placentas for laboratory or research use
5 Chemical and biological reagents for use in vitro diagnostic test kits for medical diagnostic use; chemical and biological peptides for medical diagnostic use; chemical and biological antigens for [ medial] * medical * diagnostic use; chemical and biological mitogens for clinical or medical diagnostic use; medical, clinical and diagnostic reagents and assays for testing of body fluids, blood and plasma; whole blood; blood plasma; in vitro diagnostic test kits for use in detecting infection and cell mediated immune responses for medical and veterinary use
In the statement, Column 2, line 4 in class 5, "medial" should be deleted, and medical should be inserted.
Color is not claimed as a feature of the mark.

Trademark Events
Apr 6, 2018
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Apr 6, 2018
Death Of International Registration
Jul 27, 2017
New Representative At Ib Received
May 18, 2017
New Representative At Ib Received
Apr 28, 2017
Total Invalidation Processed By The Ib
Feb 10, 2017
New Representative At Ib Received
Feb 8, 2017
Generic Madrid Transaction Sent To Ib
Feb 8, 2017
Generic Madrid Transaction Created
Dec 16, 2016
New Representative At Ib Received
Oct 19, 2016
Total Invalidation Of Reg Ext Protection Created
Feb 19, 2016
Cancelled Section 71
Jan 27, 2013
Final Decision Transaction Processed By Ib
Jul 29, 2010
Change Of Name/Address Rec'd From Ib
Feb 21, 2010
Certificate Of Correction Issued
Feb 20, 2010
Case Assigned To Post Registration Paralegal
Feb 18, 2010
Teas Section 7 Request Received
Oct 21, 2009
Final Disposition Notice Sent To Ib
Oct 21, 2009
Final Disposition Processed
Oct 14, 2009
Final Disposition Notice Created, To Be Sent To Ib
Jul 14, 2009
Registered-Principal Register
May 15, 2009
Notification Of Possible Opposition - Processed By Ib
Apr 30, 2009
Notification Of Possible Opposition Sent To Ib
Apr 30, 2009
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 28, 2009
Published For Opposition
Apr 8, 2009
Notice Of Publication
Mar 23, 2009
Law Office Publication Review Completed
Mar 22, 2009
Approved For Pub - Principal Register
Mar 20, 2009
Teas/Email Correspondence Entered
Mar 19, 2009
Correspondence Received In Law Office
Mar 19, 2009
Teas Response To Office Action Received
Dec 8, 2008
Non-Final Action Mailed
Dec 5, 2008
Non-Final Action Written
Dec 3, 2008
Previous Allowance Count Withdrawn
Sep 22, 2008
Withdrawn From Pub - Og Review Query
Sep 5, 2008
Law Office Publication Review Completed
Sep 4, 2008
Approved For Pub - Principal Register
Jun 27, 2008
Teas/Email Correspondence Entered
Jun 27, 2008
Correspondence Received In Law Office
Jun 27, 2008
Assigned To Lie
Jun 27, 2008
Teas Response To Office Action Received
Jan 25, 2008
Refusal Processed By Ib
Dec 28, 2007
Non-Final Action Mailed - Refusal Sent To Ib
Dec 28, 2007
Refusal Processed By Mpu
Dec 28, 2007
Non-Final Action (Ib Refusal) Prepared For Review
Dec 27, 2007
Non-Final Action Written
Dec 18, 2007
Assigned To Examiner
Nov 30, 2007
New Application Entered In Tram
Nov 29, 2007
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24